Public Profile

HistoGeneX

HistoGeneX, headquartered in Belgium, is a leading provider in the field of precision medicine and pathology services. Founded in 2005, the company has established itself as a key player in the biopharmaceutical industry, specialising in advanced histopathology and biomarker analysis. With operational regions spanning Europe and North America, HistoGeneX offers a comprehensive range of services, including tissue diagnostics and digital pathology solutions. The company is renowned for its innovative approach to histology, utilising cutting-edge technology to deliver high-quality, reproducible results. HistoGeneX's commitment to excellence has positioned it as a trusted partner for pharmaceutical companies and research institutions, contributing to significant advancements in personalised medicine. With a strong focus on quality and customer satisfaction, HistoGeneX continues to achieve notable milestones in the evolving landscape of healthcare.

DitchCarbon Score

How does HistoGeneX's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

6

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

HistoGeneX's score of 6 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

HistoGeneX's reported carbon emissions

HistoGeneX, headquartered in Belgium (BE), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. While there are no documented reduction targets or climate pledges available, it is essential to note that many companies in the life sciences sector are increasingly focusing on sustainability and carbon neutrality. HistoGeneX may be engaging in similar initiatives to align with industry standards and contribute to global climate goals. For a comprehensive understanding of HistoGeneX's climate commitments and emissions profile, further information would be required.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HistoGeneX's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. HistoGeneX is headquartered in BE, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

HistoGeneX is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

FOUNDATION CONSUMER BRANDS

US
Research Services
Updated 10 days ago

ARPO BMB

AR
Research Services
Updated 10 days ago

BLRH Biotech Co., Ltd.

CN
Research Services
Updated 10 days ago

TNS Group Holdings Limited

GB
Research Services
Updated 3 days ago

Denominator

US
Research Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers